| EM | Electromagnetic |
| G1 phase | First gap phase |
| S phase | Synthesis phase |
| G2 phase | Second gap phase |
| M phase | Mitosis phase |
| ROS | Reactive oxygen species |
| CKIs | Cyclin-Dependent Kinase Inhibitors |
| CDKs | Cyclin-Dependent Kinases |
| CDK4 | Cyclin-Dependent Kinase 4 |
| CDK6 | Cyclin-Dependent Kinase 6 |
| CDK2 | Cyclin-Dependent Kinase 2 |
| ATM | Ataxia Telangiectasia Mutated |
| ATR | Ataxia Telangiectasia and Rad3 Related |
| CHK1 | Checkpoint Kinase 1 |
| VGCCs | Voltage-gated calcium channels |
| EMF | Electromagnetic field |
| ELF | Extremely low-frequency |
| PMF | Pulsed low-frequency |
| TFF2 | Trefoil Factor 2 |
| VNS | Vagus nerve stimulation |
| MDSCs | Myeloid-derived suppressor cells |
| miRNA | microRNA |
| NSMF | Non-sinusoidal magnetic field |
| RoMEA | Relative oxygen metabolic efficiency assay |
| EIT | Electrical impedance tomography |
| BIS | Bioimpedance spectroscopy |
| HTS | High-throughput screening |
| GBM | Glioblastoma |
| TMZ | Temozolomide |
| PFS | Progression-free survival |
| OS | Overall survival |
| TTP | Time to progression |
| MF | Magnetic field |
| AI | Artificial intelligence |
| MNPs | Magnetic nanoparticles |
| RFA | Radiofrequency ablation |
| LIPUS | Low-intensity pulsed ultrasound |
| LIPUS | Low-intensity pulsed ultrasound |
| MWA | Microwave ablation |